LabBase Doctor・PostDoctor
ja/en How to use
ja/en How to use Contact
Home

Recruit Detail

Company Name

National Research and Development Agency National Institute for Quantum and Radiological Science and Technology

Occupation

Fixed-Term Full-Time Staff

Work Detail

(1) Research and development of synthesis and analysis technology for radiopharmaceuticals for treatment and diagnosis (2) Manufacturing and quality control of radiopharmaceuticals for treatment and diagnosis (3) Maintenance and management of PET drug contract analysis services

Ideal Profile

(1) Must have a bachelor's degree in pharmaceutical science or engineering (science, pharmacy, etc.). (2) Must have experience in radiopharmaceutical synthesis and handling. (3) Must have experience in instrumental analysis and organizing and analyzing analytical data.

Work Location

Chiba area (Chiba)

Phd. Stating Salary

Annual salary system, determined based on the organization's regulations (Model annual income: https://www.qst.go.jp/soshiki/8/31698.html)

Selection Flow

① Performance review (oral presentation using PowerPoint, etc. and Q&A) ② Interview screening

External Site

https://job.axol.jp/vb/c/qst/public/top/

Similar Recruits

Sumitomo Electric Industries, Ltd.

Occupation
Development of synchrotron radiation analysis technology

① Material analysis using synchrotron radiation and laboratory analysis equipment. Software control of analytical equipment and development of analytical data processing programs. ② Analysis technology development and data utilization using quantum beams such as synchrotron radiation. Maintenance and management of equipment (vacuum equipment, X-ray detectors, etc.). *After working at Itami Works for about 3 years, he worked at Saga (SAGA-LS stationed) for about 3 years. Possible <Scope of change> Planning and coordination of general affairs, human resources, accounting, sales, business plans, etc. Investigation work, design, production technology, Professional technical work such as sales technology, research and development

2025年卒 2026年卒

Nikon Corporation

Occupation
biotech engineer

・Planning and execution of joint development with external researchers ・Collect information on future technologies and new applications related to basic/drug discovery/medical fields (pathology/ART) ・Principle verification experiment of technology using biosamples

2025年卒 2026年卒

Knowledge Palette Co., Ltd.

Occupation
Experimental omics field (researcher)

Would you like to develop transcriptome analysis technology with the world's highest accuracy and highest throughput? We are looking for researchers who can work with us to develop platform technologies for data-driven new drug creation and practical application of regenerative medicine. Our single cell transcriptome analysis technology won first place in accuracy score at the 2020 International Benchmark Competition. Additionally, large-scale bulk transcriptome analysis technology boasts tens of times the throughput compared to conventional RNA-seq technology. However, there is still room for the development of these technologies, and we would like to further evolve them into technologies that stand out in the life science industry and accelerate the development of new drugs for patients with intractable diseases. We are looking for motivated researchers who want to develop the world's first technology and contribute to patients. 【in particular】 ・Research to improve the quantitative and qualitative throughput of single-cell/large-scale transcriptome analysis technology to improve efficiency by an order of magnitude or more ・Research to advance elemental technologies through laboratory automation and significantly improve the data acquisition process ・Technology development to expand acquired data, such as introduction of high-throughput technology to simultaneously measure omics information other than transcriptome ・Development of new single-cell/large-scale transcriptome analysis technology [Other ongoing research projects] ・In-house research on cell control that integrates single-cell/large-scale transcriptome analysis technology and cell culture optimization technology to improve culture condition screening throughput by more than two orders of magnitude compared to current levels ・In-house research to acquire genetic profile data and metadata of "multiple types of cell lines x various cell states" and build our own integrated database ・Joint research with other companies (including academia) that conducts phenotypic drug discovery and clinical biomarker discovery using single-cell/large-scale transcriptome data ・Joint research with other companies (including academia) to search for quality markers for cell medicines and optimize cell culture conditions Depending on suitability, etc., we may order you to transfer to work specified by the company.

2025年卒